17 beta-hydroxy-4-estren-3-one laurate, a new long-acting anabolic steroid.
D000293:Adolescent; D000328:Adult; D000368:Aged; D045930:Anabolic Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D001798:Blood Proteins / Q000032:analysis; D001835:Body Weight / Q000187:drug effects; D003692:Delayed-Action Preparations; D004361:Drug Tolerance; D005260:Female; D006331:Heart Diseases / Q000188:drug therapy; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D007273:Injections, Intramuscular; D008107:Liver Diseases / Q000188:drug therapy; D008171:Lung Diseases / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009132:Muscles / Q000187:drug effects; D009497:Neurotic Disorders / Q000188:drug therapy; D010024:Osteoporosis / Q000188:drug therapy; D013272:Stomach Diseases / Q000188:drug therapy
D045930:Anabolic Agents; D001798:Blood Proteins; D003692:Delayed-Action Preparations; D006454:Hemoglobins